Khat leaves originate in East Africa and the Arabian Peninsula and are chewed socially for their psychoactive properties. The main constituents of khat, cathinone and cathine, are illegal substances in most of Europe, including the UK, which reclassified khat as a Class C drug in June 2014. Case reports of khat-induced psychosis and dependence are not supported with robust scientific studies, and evidence for a causal relationship is lacking. Cross-sectional population studies reveal that khat abuse is affected by a range of susceptibility factors, such as psychological trauma; this has been experienced by many khat users, due to civil war and/or migration. Most studies on animal models of khat-induced dependence or psychosis use its psychoactive ingredient, cathinone, rather than khat extract. However, the unique chewing method of khat diminishes its addictive potential due to slow and prolonged absorption. Furthermore, the effects of the other constituents present in khat leaves are not well understood. While there are multiple criteria for banning a drug, this review considers the scientific evidence regarding two frequently mentioned criteria: dependence potential and psychosis. It concludes that further investigation, which takes into account susceptibility factors, is required to justify such intervention.
Introduction
The following literature review provides a synthesis of khat-related scientific research papers and governmental reports, with a view to assessing the validity of reports made about the side effects of khat use. The bibliography was compiled using NCBI searches and an assessment of governmentally commissioned reports. It must be noted that due to the rapid spread of khat use across North Africa and into Europe and Asia, prevalence statistics may only be transiently accurate. Furthermore, as this literature review concerns the prevalence of khat use in the UK, it is important to reflect on the need for more such studies in the UK and Europe, as currently the majority of relevant literature has been conducted in Africa and the Middle East. This also leaves little scope for elimination of confounding factors such as civil war and migration when assessing psychiatric side effects.
The leaves of the Catha edulis plant, commonly known as khat, are habitually chewed for their psychoactive properties (Halbach, 1972) by an estimated 55% of the Somali population (Elmi, 1983) and 85% of Yemeni adult males (Pantelis et al., 1989) . Although these are the most recent prevalence studies, they were conducted before the Somali civil war, and therefore, this is likely to have changed. Furthermore, the Yemeni studies have been conducted in limited areas and are not representative of the entire population. A study conducted in 2005, although confined to four British cities and therefore not representative of Britain as a whole, found that 51% of male Somalis had chewed khat within the last month, contrasting with 14% of women (Patel et al., 2005) . Khat chewing is thus a male-dominated activity, chewed socially in homes or cafe´s known as 'mafreshis'. Before the 2014 UK ban, khat was Kenya's most profitable export, as global migration patterns have created a global market for khat trade (Carrier, 2007) .
The main psychoactive constituent of khat is the monoamine alkaloid, cathinone (S(-)a-aminopropiophenone), which has a similar pharmacological profile to amphetamine. Cathinone begins to degrade into cathine (S,S(þ)norpseudoephedrine) and norephedrine (R,S(-)norpseudoephedrine) upon harvesting, which are thought to have relatively little psychoactive effect, yet contribute unwanted side effects. To retain freshness, khat is wrapped in banana leaves upon harvesting and is chewed preferentially within 36 h; the economic value of khat appears to correlate with freshness and therefore supposedly cathinone content (Geisshu¨sler and Brenneisen, 1987) . However, this oversimplified view is contested by Carrier, suggesting that factors such as farming and trade costs, seasonality, demand and risk affect economic value. Therefore, buyers cannot be guaranteed higher cathinone content among more expensive khat batches (Carrier, 2007) .
Cathinone and cathine are controlled under the Misuse of Drugs Act 1971 as Class B substances. This was followed by the emergence of 'legal highs': synthetic cathinones such as methcathinone and mephedrone. Following a review by the Advisory Council on the Misuse of Drugs (ACMD, 2010), a recommendation was made to reclassify synthetic cathinones as a Class B drug, culminating in a UK ban in 2010. Khat, however, despite being mostly banned in Europe due to its 1% cathinone content, has until recently remained legal in the UK. Although the governmentally commissioned ACMD report (ACMD, 2013) found insufficient evidence for the ban, the government has reclassified khat as a Class C drug. Class C is the lowest classification in the Misuse of Drugs Act; however, the drugs listed are still considered by the Home Office to hold significant health and societal risks.
The UK khat users affected by the ban are almost exclusively from within immigrant communities. Supporters of the ban report that khat is addictive, psychosis-inducing, detrimental to family life and peripherally damaging, causing oral carcinoma, cardiovascular disease and hepatotoxicity. In fact, there is even an Ethiopian term 'jezba' for khat-induced psychosis (Kalix, 1990) . However, opposition cites it as an important part of cultural heritance, or even foodstuff, and it has traditionally been used for its medicinal properties, treating depression, hunger during famine and fatigue among combatants (Kalix, 1990) . Furthermore, the economic value of khat is so high that countries such as Kenya receive a greater profit from khat exports than from other crop exports (Carrier, 2007) .
The societal implications of the physiological effects are of undeniable importance when deciding to ban a drug, and there are many considerations which must be made, some of which are beyond the scope of this review (ACMD, 2013) . The evidence for khat-induced psychiatric conditions is less clear than for some of the psychiatric physiological effects and may pose greater societal risk. Therefore, this review will evaluate the scientific evidence for khat dependence and induced psychosis.
Pharmacokinetics
Fresh khat leaves contain over 40 different alkaloids, at low concentrations and in varying quantities (Elmi, 1983; Wabe, 2011) . It is thought that these confer minimal psychoactive effect as chewing fresh khat leaves elicits similar behaviour to an intravenous cathinone dose; however, cathinone-free khat does not (Kalix, 1991) . Chewing khat, typically over 2 to 3 h, liberates the alkaloids slowly, and users consume 100-500 g of khat. There is an average concentration of 36 mg cathinone, 120 mg cathine and 8 mg norephedrine in every 100 g of khat (Kalix, 1996) .
The euphoria, talkativeness, anorexia, insomnia, hypertension and hyperthermia experienced are similar to, but milder than, those induced by amphetamines. Onset within 30 min (Cox, 2003) implies that absorption initially occurs across the oral mucosa, with subsequent absorption occurring across the stomach lining from the juices swallowed (Toennes et al., 2003) . Measuring plasma levels of khat users live shows that the maximal plasma concentrations of cathinone occur around 2 h, with a half-life of 3 h (Kalix and Braenden, 1985) . Depression, insomnia and irritability may follow the desired effects and last a few hours.
Cathinone's high lipid solubility gives it greater access to the central nervous system, accounting for its stronger psychostimulant properties (Kalix and Braenden, 1985) than the other constituents. Cathine is up to 10 times less potent than cathinone (Nencini and Ahmed, 1989) ; however, it is thought to mediate unwanted side effects such as nausea by acting on the sympathetic nervous system (Cox, 2003) . Considering the low cathinone content of khat, it is surprising that little is known about the pharmacology of its other constituents. In the liver, cathinone undergoes first pass metabolism into cathine and norephedrine (Al-Obaid et al., 1998) at the same rate as absorption, accounting for its short-lived effects and maximal cathinone plasma level limit. This metabolism reduces the action on dopamine 15-fold, suggesting that cathinone is responsible for dopamine-related behavioural effects (Rothman, 2003) .
Neuropharmacology
Drugs with addictive potential are thought to increase the synaptic dopamine levels in the mesocorticolimbic pathway, which is critical in reward and reinforcement (Adinoff, 2004 ). Cathinone appears to affect monoaminergic reuptake and release in a similar way to amphetamine (Hadlock et al., 2011) . Radiolabelling dopamine in the rat nucleus accumbens (NAcc), caudate nucleus and striatum shows that cathinone-induced release is three times less potent than amphetamine (Kalix, 1984) . In vivo microdialysis has shown that both cathinone and amphetamine increase presynaptic dopamine by 50% in the rat NAcc and anterior caudate (Kehr et al., 2011; Pehek et al., 1990 ) and attenuation upon dopamine receptor blockade (Al-Obaid et al., 1998) . It is thought that cathinone is most potent at D1 receptors (Gosnell et al., 1996) . However, an interesting study places doubt on the reliability of in vitro experiments to reflect behaviour in vivo; cathinone decreased dopamine and serotonin (5-HT) reuptake following cathinone treatment in vivo, but in vitro, did not (Fleckenstein et al., 1999) .
A greater ratio of dopamine affinity to 5-HT receptor affinity is thought to increase a drug's addictive potential (Wee et al., 2004) . Cathinone induces release of radiolabelled 5-HT in rat striatal tissue (Kalix, 1984) and appears to have a greater 5-HT receptor affinity than amphetamine (Glennon and Liebowitz, 1982) ; therefore, cathinone should have the lower addictive potential. However, this is controversial, with reports that cathinone is highly potent at dopamine compared to 5-HT transporters (Aarde et al., 2013) . Further investigation is required into the interactions between the dopaminergic and serotonergic systems and their indirect modulatory mechanisms. Therefore, further study is required to improve the understanding of khat pharmacology, especially as the other constituents are not well documented.
Dependence
Animal models have been essential in understanding the behavioural effects of cathinone, as the effects of khat in humans are mainly derived from case studies. Animal models imply that khat has the pharmacological propensity for addiction; however, the range of human addiction prevalence is reported at between 0.6% (Alem et al., 1999) and 40% (Kassim and Croucher, 2006) . Human habitual users express little difficulty in stopping (ACMD, 2013) , and withdrawal symptoms are reportedly mild (Sulzer et al., 2005) .
The viability of modelling human khat use on animal studies is questionable as the entire extract is rarely used, and the majority of studies use cathinone rather than khat. For the purposes of this discussion, khat's addictive potential will be considered by assessing aversion, reinforcement and drug discrimination in animal models using cathinone. The lack of data using pure khat extracts reflects the need for a more accurate representation of its effects; however, as cathinone is the main alkaloid causing the psychoactive effects, it is to an extent useful in discussing the effects of khat. Furthermore, intravenous cathinone doses have been shown to elicit similar responses in humans to chewing khat, whereas cathinone-free khat did not (Kalix, 1991) .
A drug's aversive properties can be assessed by using conditioned taste aversion (CTA), where drug administration is paired with a taste, which the animal subsequently becomes averse to (Goudie, 1979) . Although between-study comparisons of CTA in response to cathinone and amphetamine suggests that cathinone is less aversive, direct comparison using identically controlled methodology has not been conducted, and as behavioural experimentation is so sensitive to this, this may be an unreliable conclusion. Indeed, even the number of bottles available in choice paradigm studies is reputed to affect consumption in rats (Tordoff and Bachmanov, 2003) . Low aversion of cathinone has also been observed through the induction of conditioned place preference (Schechter and McBurney, 1991) . Reinforcement can be assessed by self-administration experiments. Rhesus monkeys maintain intravenous self-administration of amphetamine and cathinone at similar levels, despite the lower potency of cathinone (Johanson and Schuster, 1981) which reflects cathinone's highly reinforcing nature. Similar comparison with cocaine using a discrete-trial choice paradigm has revealed equal reinforcement (Woolverton and Johanson, 1984) . However, this was found to be dosedependent; at higher doses, comparatively more cocaine was required to maintain preference. Therefore, while this implies that cathinone is a highly strong reinforcer at high doses, however, sufficient cathinone cannot be extracted by chewing (Halket et al., 1995) .
Physiological tolerance has been reported in khat users, as peripheral stimulant effects are reduced in chronic compared with novel users (Nencini et al., 1984) . Tolerance to cathinone in rats using the drug discrimination paradigm develops after 10 days of chronic intravenous administration and reverses after 15 days of cessation (Schechter, 1986) . This suggests there is significant, but short-lived tolerance.
The dopamine antagonist haloperidol diminishes rats' discriminative ability between cathinone and amphetamine, suggesting that presynaptic dopamine release is required for the interoceptive cue properties of cathinone. However, this diminishment only occurred 50% of the time, suggesting that other pathways or indirect actions on dopamine are affected by cathinone (Goudie and Newton, 1985) . This combination of low aversion, high reinforcement efficacy and development of tolerance implies that cathinone is at high potential for uncontrolled use. However, the self-limiting dosage and slow-onset route (Halbach, 1972) of khat administration diminishes this possibility, as higher doses of any drug generally lead to higher reinforcement (Herrnstein, 1961) . The possibility is further decreased as the duration and speed of action were not controlled for in the above studies; slow consumption of khat reduces this potential. However, an underestimate is equally possible; most studies use racemic mixtures of cathinone, rather than the naturally occurring enantiomer, which is several times more potent (Sulzer et al., 2005) . Furthermore, chronic drug use is difficult to mimic because animal studies are carried out within a short time frame (Nyongesa et al., 2013) .
Psychosis
In experimental animals, there is frequently a correlation between amphetamine-induced psychosis and behavioural sensitisation (Robinson and Becker, 1986) . This is reflected in case studies documenting khat-induced psychosis (Kalix, 1991) . However, there are thought to be key, but controversial differences, with some proposing that khat-induced psychosis does not outlast consumption, whereas amphetamine psychosis is persistent (Sato, 1992) . Indeed, even if no causation between psychosis and khat use is derived, it is still important to investigate why a certain group of people are more likely to compulsively use drugs, so targeted prevention strategies can be put in place. Amphetamine-induced psychosis is considered multifactorial, the contributing factors including sensitisation, genetics and environmental vulnerability. Although these have not all been explored exclusively with khat, there is an emerging view that environmental stress is a significant vulnerability factor, and this is difficult to control for in animal models.
Pre-pulse inhibition (PPI), which is defective in both humans with schizophrenia, and corresponding animal models, is thought to indicate psychosis, and it is used as part of the assessment of antipsychotic success (Feifel, 1999) . PPI deficits and locomotor hyperactivity in rats (thought to be indicative of psychosis due to enhanced dopamine transmission (Braff et al., 2001) ) have been observed in response to a dose of khat equivalent to that consumed during a typical human session (1 mg cathinone/kg body weight) and a pure cathinone dose (1.5 mg/kg). Greater and persistent behavioural sensitisation was observed in cathinone compared with khat extract and was rescued by the atypical antipsychotic clozapine. However, challenge with cathinone a week after clozapine administration ceased, elicited no sensitisation, implying acute sensitisation. While this could represent the increased risk of developing psychosis after khat use, greater effects were elicited by cathinone, with often khat extract eliciting only slightly different effects to saline (Banjaw et al., 2005) .
Subsequent neurochemical analysis performed on the rat brains showed decreased 5-HT levels in the NAcc and increased dopamine in the prefrontal cortex (PFC), in concert with the dopaminergic theory of schizophrenia. However, as clozapine appears to decrease 5-HT levels in NAcc (Ferre´and Artigas, 1995) , the reduced level cannot be attributed exclusively to psychosis and not clozapine. Furthermore, as clozapine relieves some negative symptoms of schizophrenia, thought to be due to glutamate-mediated dopamine release in the PFC (Chen and Yang, 2002) , it is unclear whether decreased dopamine levels are due to cathinone or clozapine.
Increased levels of the transcription factor ÁFosB observed in the hamster striatum and suprachiasmatic nucleus following cathinone administration indicate location-specific enhanced activity, whereas other cathinone derivatives, such as mephedrone, appear to cause a more widespread increase. These areas are high in D1 receptors, and therefore the increased levels may indicate enhanced dopaminergic activity, which implies increased addictive potential (Jones et al., 2014) .
Population studies
Population-wide studies are important in determining the prevalence of psychiatric conditions among khat users. A study on Somali khat users compared psychosis between khat and non-khat users in a large warstricken population, an important parameter to take into account. Although psychosis correlated with khat consumption, psychosis also correlated with psychological trauma, such as military experience. Interestingly, trauma was strongly correlated with khat consumption. Therefore, although a clear relationship can be derived between psychosis, trauma and khat use, a causative one cannot be (Odenwald, 2005) . However, men were found to have seven times the rate of psychosis as women, far exceeding the standard ratio. Despite a possible attribution to higher khat consumption in males, the study neglected genderspecific trauma differences, as women and men's experiences of war may be very different. Furthermore, the age at which khat use begins may correlate with amount of trauma experienced, providing a further confounding factor. Soldiers (often khat users) are likely to be young adults or even children, whereas social users are more usually older men, and so the younger combatants may experience more trauma than their older male counterparts. Thus, age of onset of khat use is another variable that warrants consideration (Farrell, 2002) .
The relationship between trauma and psychosis can be more closely examined by looking at a study on Yemeni students, state officials and housewives in a comparatively peaceful area (Numan, 2004) . Interestingly, no association between psychiatric conditions and khat use was found and in fact reported an improved reaction to phobias among users.
Migration, especially when escaping a war-torn home, as the majority of Somali migrants will have done, is likely to induce significant stress. The difficulty of deriving a causal relationship is exacerbated by the fact that first-generation immigrants are the only group who appear to regularly consume khat and have also likely experienced trauma. An attempt to address the link by a South London Somali cross-sectional study found that while khat use did not correlate with psychosis or trauma, psychosis and trauma were correlated (Bhui and Warfa, 2010) . This study strongly supports moving away from a clear khat-psychosis relationship and towards a complex one involving many vulnerability factors.
Discussion
Evidence from animal studies suggests that cathinone has addictive potential and increases psychotic symptoms. However, these have been conducted in a limited range of species, between which the pharmacokinetics and metabolism of drugs can vary remarkably. Therefore, translatability to humans cannot be assumed, especially as the slow-onset method of khat consumption diminishes these risks. In contrast to the well-documented psychiatric physiological harms of khat, most recent publications on the psychiatric effects of khat have been literature reviews. This reflects the need for generation of original scientific research.
Although there are clearly correlations between psychosis and khat consumption, there are too many contributing factors to implicate causation. If we are to understand the real potential of khat to induce psychosis, future studies on humans controlling for age, gender, poly-drug use and previous trauma (Tulloch et al., 2012) are essential. For example, it would be interesting to examine psychosis prevalence among the immigrant groups who do not chew khat, and indeed other immigrant populations who do chew khat, and who are not first-generation refugees of war. Further factors such as gender and social status should be examined. The recent observation that dopamine receptor expression changes with menstrual cycles suggests that hormones may affect susceptibility to drug effects (Czoty et al., 2008) . Even social status appears to affect susceptibility to addiction; social status in non-human primates appears to affect dopamine D2 receptor expression, which may affect addiction to drugs (Nader et al., 2012) .
It is difficult to draw a line between controlled and uncontrolled drug use, and what may be considered as a normal cultural practice by some could be interpreted as drug abuse by others. Banning khat may create friction between the police and the already marginalised Yemeni and Somali communities. Although the ban may reduce use in occasional, non-dependent users, those who display addictive-like behaviour may resort to criminal use and would more likely come into contact with other more dangerous illegal drugs. It is often reported that khat users who develop psychosis are locked up without access to the drug until the phase has passed (Cox, 2003) . This reflects the lack of professional help sought for chronic khat addiction, and a ban would criminalise the most vulnerable users and deter people from addressing their psychiatric needs. A recent survey conducted among the East-African migrant population of Frankfurt looking at prevalence and reasons for khat use found that chewing khat is most often used to cope with stressful events, either past or present, and to forget negative memories. Although khat is now illegal in Germany, the prevalence of use was found to be of a level similar to countries where khat use is traditional, implying that the ban did not decrease use (Bongard et al., 2015) .
Indeed, following the US cathinone and cathine classifications in 1993, criminal activity increased, and public health did not appear to improve (ACMD, 2013) . There is also evidence that khat use has increased in countries where a ban has been enforced (ACMD, 2013) . The potential social effects of the ban were not given sufficient consideration before the ban was implemented, as reflected in the lack of information on aspects of the khat market such as adherence to standard trade regulations, buyers' profiles and age restriction. Since the ban, a retrospective survey conducted in East London found that the 'mafreshis' served as community centres for Somalis, and thus a key centre for their community has essentially been illegalised (Kassim et al., 2015) . It will be important to note how these already vulnerable communities will be affected socially and economically.
Potential benefits of khat remain largely unexplored, and the ban will hinder future research. Studies have suggested that cathinone strongly reduces catalepsy in animal models of Parkinson's disease, which could provide some relief for Parkinson's disease patients without neurotoxicity or dyskinesia side effects (Banjaw et al., 2003) . In addition, cathinone may also have some analgesic properties (Connor et al., 2000) . The traditional medicinal use of khat implies that it may confer useful therapeutic benefit, and if khat is used as a self-medication strategy to help with trauma, the ban would criminalise attempts at recovery, rather than offering support to people in need. Furthermore, the effects of the other khat constituents are poorly understood. Despite pharmacological similarity between cathinone and khat, there may be subtle behavioural effects which have been overlooked. Examining khat extract as a whole is an important step in making this distinction. Important areas for future research are emerging, such as khat-induced memory impairment (Kimani and Nyongesa, 2008) . Currently, this is only extensively documented in amphetamine studies.
The considerable economic cost of banning khat cannot be considered here; however, the ban will have been economically damaging to Kenya, which had many communities solely relying on khat export. Previously, khat imports produced a £2.9 million annual revenue for the HM Revenue and Customs (Thomas and Williams, 2013) , which is money that could have potentially been used to provide better healthcare access for problematic khat users.
Conclusion
Whether khat use becomes compulsive and triggers psychosis in vulnerable individuals, or whether these vulnerable individuals use khat as a coping mechanism remains unclear. However, there is clearly a correlation between khat use, psychosis and previous trauma. The ban on khat may criminalise attempts at promoting recovery and could potentially isolate further community members who require psychiatric help. In fact, it may even have been unnecessary, as khat consumption in younger generations appears to be on the decline in the UK. This may reflect enhanced social integration; however, it may also reflect increased exposure to alternative 'mainstream' drugs. Further robust research on khat-induced psychosis and dependence is essential for two reasons: to assess whether sufficient harm is caused on both the individual and societal levels to plan intervention to reduce these risks, and to meet the psychiatric needs of already marginalised members of the Yemeni and Somali communities. As it stands, more evidence is required to suggest that the benefits imposed by the ban will outweigh the negative consequences.
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